Anti-SARS-CoV-2 Antibody Levels Associated with COVID-19 Protection in Outpatients Tested for SARS-CoV-2, US Flu VE Network, October 2021-June 2022.
Kelsey M SumnerRuchi YadavEmma K NobleRyan SandfordDevyani JoshiSara Y TartofKaren J WernliEmily T MartinManjusha GaglaniRichard K ZimmermanH Keipp TalbotCarlos G GrijalvaJessie R ChungEric RogierMelissa M CoughlinBrendan FlanneryPublished in: medRxiv : the preprint server for health sciences (2023)
Higher anti-RBD antibodies in patients were associated with protection against symptomatic COVID-19 during emergence of SARS-CoV-2 Delta and Omicron variants.